Scientific publications

Clinical use of D-dimer in patients with cancer

Lecumberri R [SP], Pegenaute C, Páramo JA.
Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, España

Magazine: Medicina Clínica

Date: Oct 12, 2010

Haematology and Hameotherapy

ABSTRACT

There is a well-known close relationship between cancer and the haemostatic system. Plasma D-dimer (DD) is a marker of fibrin generation and lysis.

In the clinical practice, its main use is in the diagnostic algorithms of venous thromboembolism (VTE), and it is one of the diagnostic criteria of disseminated intravacular coagulation. In patients with cancer, the specificity of DD is lower than in the general population, reducing its usefulness.

However, there is a growing evidence that points out a possible application of DD in the clinical management of cancer patients as a predictor of VTE, marker of hidden cancer in patients with idiopathic VTE, or even as an independent prognostic factor of response to chemotherapy and survival.

In this review, the current evidence supporting the use of DD in cancer patients is critically exposed and discussed.

CITA DEL ARTÍCULO  Med Clin (Barc). 2010 Nov 11

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra